Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.45499 | 18 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.63992 | 28 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.42047 | 17 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.34848 | 16 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.36883 | 17 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.50585 | 19 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.43634 | 17 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.40254 | 17 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.38669 | 17 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.43815 | 19 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.49291 | 21 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.39525 | 17 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.42039 | 17 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.81054 | 36 |